Clinical trial
Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients
NCT00292526 · European Institute of Oncology, Other · Completed
Key facts
| NCT number | NCT00292526 |
|---|---|
| Title | Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients |
| Official title | Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients |
| Lead sponsor | European Institute of Oncology, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiotoxicity, Chemotherapeutic Toxicity |
| Intervention type | Drug |
| Interventions | Enalapril |
| Enrollment | 114 |
| Start date | Nov 1, 2000 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Feb 16, 2006 |
| Last update posted | Feb 9, 2017 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: